CompletedNot Applicable

A Personalized and Interactive Web-based Health Care Innovation to Advance the Quality of Care

Denmark478 participantsStarted 2017-02-06

Plain-language summary

This study evaluates the clinical efficacy and cost-effectiveness of the ACQUIRE-ICD care innovation as add-on to usual care as compared to usual care alone in patients with an implantable cardioverter defibrillator.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a first-time ICD or CRT-D * ≥18 years of age Exclusion Criteria: * Subcutaneous ICD * Upgrade from a pacemaker to ICD or CRT * History of psychiatric illness other than affective/anxiety disorders * Cognitive impairments (e.g. dementia) * Left ventricular assist device (LVAD) or upcoming LVAD implant * Under evaluation or on the waiting list for heart transplantation * No e-mail address * Inability to manage or cope with computer technology * Insufficient knowledge of the Danish language * Participation in other randomized controlled trials unless of a technical nature * Irresponsible to ask patient to participate according to GCP

What they're measuring

Device acceptance

Timeframe: 12 months

Trial details

NCT IDNCT02976961

SponsorSusanne Schmidt Pedersen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Implantable Defibrillator User trials